Quinoline based mono- and bis-(thio) carbohydrazones: synthesis, anticancer activity in 2D and 3D cancer and cancer stem cell models
| dc.contributor.author | Bozic, Aleksandra | |
| dc.contributor.author | Marinkovic, Aleksandar | |
| dc.contributor.author | Bjelogrlic, Snezana | |
| dc.contributor.author | Todorovic, Tamara R. | |
| dc.contributor.author | Cvijetic, Ilija N. | |
| dc.contributor.author | Novakovic, Irena | |
| dc.contributor.author | Muller, Christian D. | |
| dc.contributor.author | Filipovic, Nenad R. | |
| dc.date.accessioned | 2026-11-05T11:00:08Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | A comparative study of antitumor activity of mono- and bis-quinoline based (thio) carbohydrazones was investigated by a series of tests on two human malignant cell lines: acute monocytic leukemia (THP-1) and pancreatic adenocarcinoma cancer stem cells (AsPC-1). Thiocarbohydrazones (TCHs) revealed superior pro-apoptotic activity over carbohydrazones (CHs) on both tested cell phenotypes, also displaying multi-target profile activities. Programmed cell death triggered by TCHs was partially caspase-dependent, mainly caspase-8 related. Activity against cancer stem cells (CSCs) was evaluated on 2D monolayers and 3D spheroidal models, where two out of three tested bis-TCHs successfully stimulated apoptosis accompanied by a reduction in size of treated spheres. Additionally, all bis-TCHs induced significant decrease in percentage of CD44-expressing AsPC-1 cells that indicate on their ability to induce reprogramming of CSC phenotype. Current results highly support further assessment of bis-TCHs in order to specify their specific targets in cancer cells and particularly in the CSCs subpopulation. | |
| dc.description.issue | 106 | |
| dc.description.pages | 104763-104781 | |
| dc.description.sponsorship | The authors acknowledge networking support by the COST Action CM1106 StemChem - Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells. The work was funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grants 172055 and 172013). | |
| dc.description.volume | 6 | |
| dc.identifier.doi | 10.1039/c6ra23940d | |
| dc.identifier.issn | 2046-2069 | |
| dc.identifier.uri | https://doi.org/10.1039/c6ra23940d | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/10349 | |
| dc.identifier.wos | WOS:000388111900107 | |
| dc.language.iso | en | |
| dc.publisher | ROYAL SOC CHEMISTRY | |
| dc.relation.funding | COST Action CM1106 StemChem - Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells | |
| dc.relation.funding | Ministry of Education, Science and Technological Development of the Republic of Serbia | |
| dc.relation.funding | Ministry of Education, Science and Technological Development of the Republic of Serbia [172055, 172013] | |
| dc.relation.hasversion | 10.1039/c6ra23940d | |
| dc.relation.ispartof | RSC ADVANCES | |
| dc.subject | BIOLOGICAL-ACTIVITIES | |
| dc.subject | METAL-COMPLEXES | |
| dc.subject | DRUG DISCOVERY | |
| dc.subject | SERUM-ALBUMIN | |
| dc.subject | IN-VITRO | |
| dc.subject | THIOSEMICARBAZONES | |
| dc.subject | DERIVATIVES | |
| dc.subject | REDUCTASE | |
| dc.subject | ANTITUMOR | |
| dc.subject | TRIAPINE | |
| dc.subject | Chemistry, Multidisciplinary | |
| dc.subject | Chemistry | |
| dc.title | Quinoline based mono- and bis-(thio) carbohydrazones: synthesis, anticancer activity in 2D and 3D cancer and cancer stem cell models | |
| dc.type | Article | |
| oaire.citation.edition | Science Citation Index Expanded (SCI-EXPANDED) | |
| oaire.citation.endPage | 104781 | |
| oaire.citation.issue | 106 | |
| oaire.citation.startPage | 104763 | |
| oaire.citation.volume | 6 | |
| person.identifier.orcid | 0000-0001-9881-1204 | |
| person.identifier.orcid | 0000-0002-1910-4729 | |
| person.identifier.orcid | 0000-0003-2982-5324 | |
| person.identifier.orcid | 0000-0002-5568-6172 | |
| person.identifier.orcid | 0000-0002-6790-0287 | |
| person.identifier.orcid | 0000-0002-7740-3639 | |
| person.identifier.orcid | 0000-0003-3239-5476 | |
| person.identifier.orcid | 0000-0002-3463-1025 | |
| person.identifier.rid | G-3418-2012 | |
| person.identifier.rid | B-5402-2018 | |
| person.identifier.rid | AAF-3199-2020 | |
| person.identifier.rid | P-8803-2016 | |
| person.identifier.rid | F-8399-2010 |
